Saint Barnabas Medical Center Offers New Treatment for Patients With Gastroenteropancreatic Neuroendocrine Tumors
November 26, 2019
November 26, 2019
NEW BRUNSWICK, New Jersey, Nov. 26 -- Saint Barnabas Medical Center, a hospital operated by RWJBarnabas Health, issued the following news:
Saint Barnabas Medical Center (SBMC), in partnership with Rutgers Cancer Institute of New Jersey -- the state's only NCI-designated Comprehensive Cancer Center, is offering a new treatment for cancer patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs), called Lutathera(R). Lutathera is a radioactive targeted therapy that is give . . .
Saint Barnabas Medical Center (SBMC), in partnership with Rutgers Cancer Institute of New Jersey -- the state's only NCI-designated Comprehensive Cancer Center, is offering a new treatment for cancer patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs), called Lutathera(R). Lutathera is a radioactive targeted therapy that is give . . .